Slc2a10tm1Tac
Targeted Allele Detail
|
|
| Symbol: |
Slc2a10tm1Tac |
| Name: |
solute carrier family 2 (facilitated glucose transporter), member 10; targeted mutation 1, Taconic |
| MGI ID: |
MGI:6510237 |
| Gene: |
Slc2a10 Location: Chr2:165345817-165361837 bp, + strand Genetic Position: Chr2, 85.66 cM
|
| Alliance: |
Slc2a10tm1Tac page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:295974
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
Not Specified
|
|
| Allele Type: |
|
Targeted (Null/knockout) |
| Mutation: |
|
Insertion
|
| |
|
A LacZ/Neo selection cassette replaced exon 2 to through the beginning of exon 5. (J:295974)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Slc2a10 Mutation: |
29 strains or lines available
|
|
| Original: |
J:295974 Boel A, et al., Slc2a10 knock-out mice deficient in ascorbic acid synthesis recapitulate aspects of arterial tortuosity syndrome and display mitochondrial respiration defects. Hum Mol Genet. 2020 Jun 3;29(9):1476-1488 |
| All: |
1 reference(s) |
|